Kura Oncology, Inc., and Kyowa Kirin Co., Ltd. announced Kura submitted a New Drug Application (NDA) for ziftomenib, a highly selective, once-daily, oral, investigational menin inhibitor, for the treatment of…
Enyu Pharma Co., Ltd., which aims to develop medicines for diseases for…
Juntendo University and IBM Japan Ltd. announced on the 4th that they…
Daiichi Sankyo Company, Ltd has appointed Hiroyuki Okuzawa, 62, to succeed Sunao…
Pleap Inc., developer of "medimo," a medical support tool that uses AI…
Tanaka Precious Metal Technologies Co., Ltd., a company engaged in the industrial…
Takeda Pharmaceutical Company Limited announced today that its Board of Directors unanimously…
アカウントにサインインする